|
HUS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.239730E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.697800E-03 |
| Normal-vs-Stage2 |
5.443800E-01 |
| Normal-vs-Stage3 |
1.515630E-01 |
| Normal-vs-Stage4 |
3.822100E-04 |
| Stage1-vs-Stage2 |
4.027600E-01 |
| Stage1-vs-Stage3 |
8.514200E-01 |
| Stage1-vs-Stage4 |
9.826000E-02 |
| Stage2-vs-Stage3 |
6.045600E-01 |
| Stage2-vs-Stage4 |
9.638300E-02 |
| Stage3-vs-Stage4 |
2.083000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.346200E-02 |
| Normal-vs-AfricanAmerican |
2.689800E-02 |
| Normal-vs-Asian |
5.067600E-01 |
| Caucasian-vs-AfricanAmerican |
5.914200E-01 |
| Caucasian-vs-Asian |
9.512000E-01 |
| AfricanAmerican-vs-Asian |
8.961800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.159800E-04 |
| Normal-vs-Female |
5.998800E-01 |
| Male-vs-Female |
2.303600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.250020E-01 |
| Normal-vs-Extreme_Weight |
4.261200E-03 |
| Normal-vs-Obese |
7.900100E-02 |
| Normal-vs-Extreme_Obese |
1.804580E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.313000E-01 |
| Normal_Weight-vs-Obese |
8.331400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.118600E-01 |
| Extreme_Weight-vs-Obese |
3.148600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.431400E-01 |
| Obese-vs-Extreme_Obese |
4.455400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.384500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.786400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.737790E-03 |
| Normal-vs-Age(81-100Yrs) |
9.620000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.625600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.954800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.092000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.696100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.821200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.152600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.281900E-02 |
| Normal-VS-Type2 PRCC |
1.646360E-02 |
| Normal-VS-KIRP CIMP |
6.30889999999606E-05 |
| Normal-VS-Unclassified PRCC |
5.881200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.732600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.392000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.887400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.182400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.584600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.506000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.635100E-04 |
| Normal-vs-N1 |
3.046100E-02 |
| Normal-vs-N2 |
1.982810E-03 |
| N0-vs-N1 |
4.746600E-01 |
| N0-vs-N2 |
5.580600E-01 |
| N1-vs-N2 |
3.301600E-01 |
|
|
